FDA Expands Indications for Use of FibroScan® for Comprehensive Liver Management

March 22nd, 2023 FibroScan® by Echosens is now recommended for use in a larger patient population for diagnoses and management of liver disease  PARIS and Waltham, MA – March 22, 2023 – The U.S. Food and Drug Administration (FDA) has cleared expanded Indications for Use for screening with FibroScan®, the non-invasive liver management...